TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03119792

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education Intervention
Description: The education intervention will help increase the children's knowledge of attitudes, and habits of healthy lifestyles. The program will cover self care of the body and heart, emotional management, healthy diet, and physical activity.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: The control will not receive an education program relating to knowledge, attitudes, nor habits of healthy lifestyles. Instead, these sessions will occur twice a month, and will last an hour and forty-five minutes. The control program is titled Life's Challenges, which will focus on helping children develop skills necessary for day to day life, is divided into four modules: Person, Family, School, and Environment. There will be four different types of activities used throughout the program including: Lets Think, Lets Experiment, We will finish with...or synthesis, and Not here.
Study: NCT01290692

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TVI-Brain-1
Description: Following surgery, tumor tissue is used to generate a cancer vaccine. Patients are vaccinated with neutralized cells to initiate an immune response. Following vaccinations, the patient's white blood cells are collected, the white blood cells are stimulated and expanded, and are then reinfused into the patient's blood.
Study: NCT00973076

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD8055
Description: Tablets, orally administered, twice daily
Study: NCT04087525

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIP1701
Description: Vildagliptin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIP1701
Description: Vildagliptin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HGP1809
Description: Vildagliptin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HGP1809
Description: Vildagliptin
Study: NCT00708578

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glimepiride
Description: Once a day before breakfast

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glimepiride
Description: Once a day before breakfast

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Description: After breakfast and supper

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: After breakfast and supper

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Glargine
Description: Injection in the morning

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Glargine
Description: Injection in the morning

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin Glargine
Description: Injection in the morning
Study: NCT01070264

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Noni Juice
Description: This was an open label three-month intervention pilot study. Data were collected by pre and post intervention survey as well as laboratory testing. Inclusion criteria were: adults of both sexes aged 40 to 75, with a diagnosis of OA on the hip or knee by their primary care physician, not on prescription medicine for OA, and who were willing to drink 3 oz of TNJ a day
Study: NCT03304015

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Change Communications
Description: HERrespect is developed by Business for Social Responsibility (BSR) and Change Associates. HERproject is one of BSR's numerous initiatives for improving women's lives through enhancement of access and knowledge (BSR, 2015). The factory-based component of HERrespect will be implemented by Change Associates. The intervention group will receive training (group session), research and consultancy services to the corporate and development sectors. HERrespect proposes to use the workplace as an incubator of dialogue among men and women to tackle underlying issues which allow violence against women and girls. Workplace offers a unique platform and environment to engage women who are gaining financial independence to reduce intimate partner violence and workplace violence.
Study: NCT04431713

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exenatide Pen Injector [Bydureon]
Description: Exenatide is a treatment licensed for use in Type 2 diabetes.
Study: NCT01617330

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bronchoscopy
Description: Bronchoscopy with endobronchial biopsy sampling and bronchoalveolar lavage (BAL) 18 hours post exposure. Airway inflammation was assessed.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bronchoscopy
Description: Bronchoscopy with endobronchial biopsy sampling and bronchoalveolar lavage (BAL) 18 hours post exposure. Airway inflammation was assessed.
Study: NCT02911480

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxytocin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxytocin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxytocin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxytocin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxytocin
Study: NCT01317433

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxycycline
Description: Doxycycline 100 mg daily per os to start 7 days before Cetuximab for 6 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: 500 mg/m² IV infusion of 60 minutes every 15 days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cetuximab
Description: 500 mg/m² IV infusion of 60 minutes every 15 days
Study: NCT03747250

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Videolaryngoscopy
Description: In experimental group (interventional group), patients will be intubated with the videolaryngoscope

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Direct laryngoscopy
Description: In control group (active comparator group), patients will be intubated with the direct laryngoscope
Study: NCT02504021

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Consultation
Description: This intervention is based on psychoeducation, social support mobilization, and motivational interviewing techniques.
Study: NCT02702037

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: oral protein-rich supplement
Description: The older person will be offered an oral protein-rich supplement (125 ml, 18 g protein (24% of RDI), 300 kcal) twice a day in conjunction with two of the four sit-to-stand exercises during 12 weeks (7 days/week).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The older person will get up from a chair to stand and then sit down again repeatedly at least four times per day, 7 days during 12 weeks
Study: NCT00143455

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide + cisplatin
Description: etoposide 100 mg/m2 days 1, 2 and 3 cisplatin 80 mg/m2 day 1 3 week cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan + cisplatin
Description: irinotecan 65 mg/m2 day 1 and 8 cisplatin 80mg/m2 day 1 3 week cycle
Study: NCT01714271

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home environs-based lifestyle counseling
Description: Social learning theory-based behavior modification embedded in a social ecological framework is used to shape both the home environment and the lifestyle choices of the study participants to optimize their adherence to the Dietary Guidelines for Americans and the Physical Activity Guidelines for Americans.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cancer early detection
Description: Conventional health education is used to increase study participant knowledge of practical strategies for detecting and treating common cancers early, before cancers have metastasized. Additional instruction is devoted to the biology and physiology of the cancer process. Although some mention will be made of the importance of maintaining a healthy weight for minimizing lifetime risk of certain cancers, most of the focus will be on episodic cancer screening, e.g., mammograms, PAP smears, colonoscopies, etc. for prevention of death from cancer.
Study: NCT04029012

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methoxyflurane
Description: Methoxyflurane inhaler before Rezum procedure
Study: NCT01765101

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: customized insoles
Description: To study the immediate, short-term and intermediate-term therapeutic effects, including psychological function, physical activity , functional performance and quality of life, physical functional ability, pain and balance performance

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: ready made insoles
Description: To study the immediate, short-term and intermediate-term therapeutic effects, including psychological function, physical activity , functional performance and quality of life, physical functional ability, pain and balance performance
Study: NCT02335996

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Blood samples for measuring adiponectin, leptin and omentin plasma

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Blood samples for measuring adiponectin, leptin and omentin plasma

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MRI at 3 Tesla
Description: Evaluation by MRI at 3 Tesla of the amount of ectopic fat heart, liver and pancréas and bone marrow.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MRI at 3 Tesla
Description: Evaluation by MRI at 3 Tesla of the amount of ectopic fat heart, liver and pancréas and bone marrow.
Study: NCT03343587

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3375880 IV
Description: administered IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3375880 IV
Description: administered IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3375880 SC
Description: administered SC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3375880 SC
Description: administered SC

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo IV
Description: administered IV

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo IV
Description: administered IV

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo SC
Description: administered SC

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo SC
Description: administered SC
Study: NCT01962571

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erythropoietin alfa

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT01618942

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: pressure algometer

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: pressure algometer
Study: NCT00153686

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: capsule endoscopy
Description: capsule endoscopy of small intestine

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Mesenteric Angiogram
Description: Mesenteric Angiogram
Study: NCT03607838

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SI-6603
Description: SI-6603 will be injected into an intervertebral disc.

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Sham injection
Description: The injection will be performed without needle placement into an intervertebral disc.
Study: NCT03283800

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Copper impregnated compression stocking
Description: Copper impregnated compression stocking

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Normal compression stocking
Description: Normal compression stocking without copper
Study: NCT05207007

Intervention type: PROCEDURE
Intervention: Phacomulsification lens removal cataract surgery with Intraocular lens(IOL) implantation
Description: Phacomulsification lens removal cataract surgery with IOL implantation in both two groups

Intervention type: PROCEDURE
Intervention: Phacomulsification lens removal cataract surgery with Intraocular lens(IOL) implantation
Description: Phacomulsification lens removal cataract surgery with IOL implantation in both two groups
Study: NCT04286204

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Basic Life Support training based on ICTs
Description: This intervention is defined as a self-training course consisting of a 5-minute educational video in basic life support and a Kit with the elements to build the home dummy and the home DEA allowing integrally students to develop the steps as the video. The Kit will be delivered at the beginning of the study and every month the necessary materials will be complemented. The strategy will be carried out by the students every month and supervised by their teachers. Students will have constant access to an educational platform based on ICTs.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Classic Basic Life Support training
Description: It is defined as a module carried out by trained personnel in basic resuscitation (pre-hospital care program staff of the UdeA medical school), which includes two subcomponents of the conventional BLS course that are basic resuscitation and DEA in adults. The duration of the subcomponents is a theoretical part of 30 minutes and a practical part in a low fidelity simulator with 1.5 hours duration.
Study: NCT03569527

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Kiwifruit
Description: The total duration of the study will be 8 weeks (2- week baseline, 4-week intervention, and 2-week follow-up). Eligible patients will be randomized to receive kiwifruit (2 green kiwifruit per day for the 4 week intervention period.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Fiber
Description: The total duration of the study will be 8 weeks (2- week baseline, 4-week intervention, and 2-week follow-up). Eligible patients will be randomized to receive psyllium fiber (24 g/day, fiber=6g/day) for the 4 week intervention period.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Prunes
Description: The total duration of the study will be 8 weeks (2- week baseline, 4-week intervention, and 2-week follow-up). Eligible patients will be randomized to receive prunes/dried plums (100g, fiber=6 g/day) for the 4 week intervention period.
Study: NCT01119248

Intervention type: OTHER
Intervention: axillary temperature before MRI and after the MRI
Description: observation of body temperature changes with axillary temperature measurement with MRI compatible device
Study: NCT04589273

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Alginate
Description: Volunteers will be asked to consume the alginate capsules with each of their three main meals per day.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Volunteers will be asked to consume the placebo capsules with each of their three main meals per day.
Study: NCT03963635

Intervention type: DIAGNOSTIC_TEST
Intervention: MicroB-plex Lyme Immunoassay
Description: Subject's blood and clinical data are collected to develop a diagnostic immunoassay

Intervention type: DIAGNOSTIC_TEST
Intervention: MicroB-plex Lyme Immunoassay
Description: Subject's blood and clinical data are collected to develop a diagnostic immunoassay
Study: NCT01180660

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine Infusion
Description: 1.5 mg/kg bolus followed by an infusion of 2 mg/kg/hr throughout the intra operative period

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: Saline bolus equal to that of lidocaine in addition to continuous infusion of normal saline during the intra operative period
Study: NCT02790151

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Therapy
Description: Learning and practicing Memory strategies

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental Intervention
Description: Computerbased Working Memory Training in Combination with a Recollection Training
Study: NCT03014401

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroscopic debridement with stem cell transplantation
Description: Autologous fat pad harvest and transplantation of cells after standard arthroscopic treatment consisting of: partial meniscectomy, synovectomy, chondroplasty, loose body removal.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Arthroscopic debridement only
Description: standard arthroscopic treatment consisting of: partial meniscectomy, synovectomy, chondroplasty, loose body removal.
Study: NCT01258764

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lisinopril
Description: Lisinopril 10 mg oral, once daily for four week cycle and a 2 week cycle

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydrochlorothiazide
Description: Hydrochlorothiazide 25 mg oral, once daily for 4 week cycle and a 2 week cycle
Study: NCT01533376

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Timolol
Description: 0.5% timolol maleate ophthalmic gel-forming solution applied once

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Preservative free artificial tear gel.
Description: Preservative free artificial tear gel applied topically twice a day.
Study: NCT04517487

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Vaginal Microbiome Transplantation (VMT)
Description: Healthy donors vaginal fluid is introduced into recipients' vagina to replace their indigenous disease-associated microbiome

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT00455598

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ISIS 113715
Description: doses of 100 and 200 mg per week

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ISIS 113715
Description: doses of 100 and 200 mg per week
Study: NCT03033875

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tele-Savvy
Description: The Tele-Savvy program engages groups of six dementia family caregivers in a program that extends over 43 days. The program begins with a scheduled 75-minute group videoconference led by facilitators; similar group videoconferences then take place weekly for six weeks. In between the video-conferences, caregivers will receive daily emails with links to 5-15 minute on-line video lessons that can be watched on their own schedule as often as they wish. The videoconferences allow caregivers to report enactment of learned and self-developed management strategy behaviors into their own caregiving and allow them to raise questions. Each daily video presents a teaching point linked to the overall curriculum. The lesson is carried forward by brief, scripted talks by experts or is enacted in vignettes in which a fictional family caring for a father living with Alzheimer's demonstrates effective caregiving techniques linked to the day's teaching points.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Healthy Living Education Program
Description: The Healthy Living Education Program contains video and text materials on exercise, diet, and healthy living. Participants will be asked to log into the Canvas site daily over the course of six weeks to view the videos. Each participant will also receive 7 weekly brief scripted phone or video calls from a project facilitator to inquire about participants' use of the materials. Additionally, all participants will convene weekly for a video conference centered on the application of healthy living strategies. Facilitators will greet and check in with each of the caregivers, coach and debrief caregivers on the homework, answer questions and/or respond to feedback about the week's material, review key points and concepts from the week's video sessions and introduce new material, report on any activities that caregivers may have implemented based on the materials, and provide homework assignments.
Study: NCT06208592

Intervention type: DEVICE
Intervention: Sevoflurane with AnaConDa
Description: Sevoflurane administered with AnaConDa device
Study: NCT03576937

Intervention type: DIAGNOSTIC_TEST
Intervention: GUARDANT360
Description: GUARDANT360 is a validated cfDNA next-generation sequencing assay that identifies variants in 73 genes associated with several cancers.

Intervention type: DIAGNOSTIC_TEST
Intervention: GUARDANT360
Description: GUARDANT360 is a validated cfDNA next-generation sequencing assay that identifies variants in 73 genes associated with several cancers.
Study: NCT00848861

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: propofol (sedation for outpatient colonoscopy)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: midazolam plus meperidine (sedation for outpatient colonoscopy)
Study: NCT03841929

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hemodynamic report
Description: The multimodal data comprising the clinical, biochemical, NIRS data and TNE where available will be used by the study team in such cases to reach a description of the hemodynamic status of the study infant and will be provided to the Clinical team.
Study: NCT04289844

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Elastic-explosive and resistance strength
Description: The resistance exercises are: running (3 minutes), 2 farmers carrying marching, 3 side to side ankle hops, 4 plyo lunge jump, 5 lateral jump over barrier, 2 monopodalic jump with ball pass, 3 board throw with half court sprint, 4 lateral shuffle mirror, and 5 combo finisher 4x4.~Plyometric exercises are: ankle rotations, knee extension, squat, hip flexion-extension, knee and ankle, ankle mobilizations, squat with rise, pelvis ante / retroversion, global mobilization, stride

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Elastic-explosive strength
Description: Plyometric exercises are: ankle rotations, knee extension, squat, hip flexion-extension, knee and ankle, ankle mobilizations, squat with rise, pelvis ante / retroversion, global mobilization, stride
Study: NCT02683200

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Image-Guided Adaptive Radiation Therapy
Description: Undergo MRI-guided Tri-60Co teletherapy SBRT

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy
Description: Undergo MRI-guided Tri-60Co teletherapy SBRT
Study: NCT01725009

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Multiple 15-minute intravenous infusions of 1500 mg levetiracetam
Description: Strength, 100 mg/mL; Form, concentrate for solution for infusion; Frequency, twice a day; Duration, 7 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Multiple 15-minute intravenous infusions of 1500 mg levetiracetam
Description: Strength, 100 mg/mL; Form, concentrate for solution for infusion; Frequency, twice a day; Duration, 7 days
Study: NCT03308656

Intervention type: OTHER
Intervention: uterocervical angle
Description: uterocervical angle is the angle between lower segment of uterus and cervix
Study: NCT03976960

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biological collection
Description: The biological collection will also include samples of blood samples collected before or after surgery but also samples frozen and/or paraffin-embedded tissue sections.